Has Adam Duke, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,328 in general payments to Adam Duke, MD across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Adam Duke, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Adam Duke, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Adam Duke, MD

Gynecology · Post Falls, IDNPI 1710140165

Payments from drug & device makers

$7,328in general payments, 2019–2025

Across 131 payments — averaging $55.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Axonics, Inc.$2K
Coloplast$1K
Coopersurgical, Inc.$703
Stryker$696
Olympus Winter & Ibe GmbH$660
Olympus America Inc.$350
plus $1K from 21 others

What the payments were for

Consulting fees$6759%
Speaking & faculty fees$1,01014%
Travel & lodging$2,50034%
Food & beverage$3,14343%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Axonics, Inc.	42	$2,149
Coloplast	11	$1,396
Coopersurgical, Inc.	3	$703
Stryker	3	$696
Olympus Winter & Ibe GmbH	1	$660
Olympus America Inc.	1	$350
AbbVie(2 entities)	10	$194
Astellas Pharma US Inc	8	$149
GSK	6	$124
Sumitomo Pharma America, Inc.	6	$115
Merck	7	$115
Boston Scientific	2	$113
Hologic Sales And Service, LLC	4	$82
Pfizer	4	$66
Corcept Therapeutics	2	$56
Novo Nordisk	3	$53
Exact Sciences	2	$49
Organon	5	$45
AstraZeneca	2	$36
Lilly USA, LLC	2	$30
Bayer	1	$30
Amgen	1	$24
Johnson & Johnson	1	$20
Dexcom, Inc.	1	$19
Urovant Sciences Inc	1	$19
Actelion Pharmaceuticals US, Inc.	1	$18
Ascend Therapeutics US, LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few gynecology providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$32,547

Medicare patients

Services billed

167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciprofloxacin Hcl	11	$10

Paid to pharmacies, not to this prescriber.